⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21200706 | 0.95 | — | — | |
| SCHEMBL7533424 | 0.67 | — | — | |
| SCHEMBL459761 | 0.67 | — | — | |
| SCHEMBL7135436 | 0.62 | — | — | |
| SCHEMBL443045 | 0.59 | — | — | |
| SCHEMBL207875 | 0.59 | — | — | |
| SCHEMBL465091 | 0.56 | — | — | |
| SCHEMBL15416025 | 0.56 | — | — | |
| SCHEMBL16499852 | 0.56 | — | — | |
| SCHEMBL144415 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 760 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118324965-A | Modified ETFE resin, preparation method thereof and application thereof in high-flame-retardance copolymerized ETFE coating | 格林斯达(北京)环保科技股份有限公司 | 2024-07-12 | — | — | CN | claimed |
| US-11788138-B2 | Nucleic acid sequencing using affinity reagents | MGI TECH CO., LTD. (CN) | 2023-10-17 | — | — | US | claimed |
| US-20230148194-A1 | SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION | BAYER AKTIENGESELLSCHAFT (DE) | 2023-05-11 | — | — | US | claimed |
| EP-4112741-A1 | STEPWISE SEQUENCING BY NON-LABELED REVERSIBLE TERMINATORS OR NATURAL NUCLEOTIDES | MGI Tech Co., Ltd. (CN) | 2023-01-04 | — | — | EP | claimed |
| CN-115003665-A | Substituted aminoquinolones as immunoactive DGK alpha inhibitors | 拜耳公司 | 2022-09-02 | — | — | CN | claimed |
| CN-113024349-B | 3, 3-difluoro-1, 5-hexadiene compound and preparation method and application thereof | 南京工业大学 | 2022-06-07 | — | — | CN | claimed |
| EP-3565905-B1 | NUCLEIC ACID SEQUENCING USING AFFINITY REAGENTS | MGI TECH CO LTD (CN) | 2022-05-25 | — | — | EP | claimed |
| CN-110528293-B | Flame-retardant antifouling synthetic leather and preparation method thereof | 武汉天鸣集团有限公司 | 2022-01-18 | — | — | CN | claimed |
| WO-2021105117-A1 | SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION | BAYER AKTIENGESELLSCHAFT (DE) | 2021-06-03 | — | — | WO | claimed |
| CN-112778308-A | Fused tricyclic derivatives as FGFR4 inhibitors | 齐鲁制药有限公司 | 2021-05-11 | — | — | CN | claimed |
| WO-2005014580-A1 | PYRIDYL PIPERAZINYL UREAS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-02-17 | — | — | WO | claimed |
| US-20030153505-A1 | Dolastatin 15 derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2003-08-14 | — | — | US | claimed |
| US-6458765-B1 | POLYPEPTIDES AS ANTICANCER AGENTS AND AGAINST CELL PROLIFERATION | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-01 | — | — | US | claimed |
| US-6143721-A | FOR TREATING CANCER IN MAMMALS | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-07 | — | — | US | claimed |
| CN-1264388-A | Dolastatin 15 derivatives | ABSF AG (DE) | 2000-08-23 | — | — | CN | claimed |
| EP-0991658-A1 | DOLASTATIN 15 DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2000-04-12 | — | — | EP | claimed |
| WO-1999003879-A1 | DOLASTATIN 15 DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-28 | — | — | WO | claimed |
| CN-1023476-C | PROCESS OF PREPARING TRIFLUOROMETHYLVINYL DERIVATIVES STARTING WITH APPROPRIATE HALOGENOVINYL DERIVATIVES | ROUSSEL UCLAF (FR) | 1994-01-12 | — | — | CN | claimed |
| US-4920231-A | Reacting with trifluoroacetic acid with halovinyl compound in presence of cuprous salt | ROUSSEL UCLAF (FR) | 1990-04-24 | — | — | US | claimed |
| CN-1036561-A | The novel method for preparing the trifluoromethyl ethenyl derivatives from suitable halogenated vinyl derivative | ROUSSEL UCLAF (FR) | 1989-10-25 | — | — | CN | claimed |